Business Context and Reporting Period
Company: Grubb & Ellis Healthcare REIT, Inc. (Note: Metadata references Healthcare Realty Trust Inc, but filing identifies Grubb & Ellis Healthcare REIT, Inc.)
Filing Type: Form 8-K (Current Report)
Date of Report: September 30, 2008
Context: The filing discloses the completion of a significant asset acquisition and related financing activities.
Key Financial Metrics and Transaction Details
- Acquisition: Medical Portfolio 4 (5 medical office buildings in Arizona, Ohio, and Texas).
- Total Purchase Price: $48,000,000 plus closing costs.
- Financing Structure:
- Secured loan from Bank of America, N.A.: $21,400,000.
- Assumption of existing loan: $8,589,000.
- Remaining balance funded by IPO proceeds.
- Acquisition Fee: $1,440,000 (3% of purchase price) paid to the advisor and affiliate.
Note: This filing does not provide consolidated revenue, profit, cash flow, or margin data for the reporting period.
Material Changes
The primary material change is the expansion of the company's real estate portfolio through the acquisition of Medical Portfolio 4 on September 23, 2008, from unaffiliated third parties. This transaction increased the company's debt load via new secured borrowing and loan assumptions.
Outlook, Risks, and Management Commentary
Management Commentary: The company announced the acquisition via a press release incorporated as Exhibit 99.1. The transaction was funded through a mix of new debt, assumed debt, and equity raised in the initial public offering.
Risks/Contingencies: The filing does not explicitly detail new risks or contingencies beyond the standard liabilities associated with the new debt obligations and the integration of the acquired assets.
Investor Verification Checklist
- Verify the specific locations and occupancy rates of the five buildings in Medical Portfolio 4.
- Confirm the terms and interest rates of the $21.4 million secured loan from Bank of America.
- Review the terms of the assumed $8.589 million loan to understand maturity and covenants.
- Assess the impact of the $1.44 million acquisition fee on near-term cash flow.
- Confirm the utilization of IPO proceeds for the remaining purchase balance.